2008
DOI: 10.1677/joe-07-0481
|View full text |Cite
|
Sign up to set email alerts
|

Effects of early gestation GH administration on placental and fetal development in sheep

Abstract: Ovine GH (oGH) is synthesized in placental tissue during maximal placental growth and development. Our objectives were to localize oGH mRNA in the placenta, and study the impact of exogenous GH on twin pregnancies during the normal window (35-55 days of gestational age; dGA) of placental expression. In situ hybridization localized oGH mRNA in uterine luminal epithelium but not in tissues of fetal origin. While maternal GH and IGF-I concentrations were increased (P!0 . 001) approximately tenfold, uterine, uteri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2010
2010
2012
2012

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 35 publications
0
8
0
Order By: Relevance
“…2 by methods previously described by this laboratory (Warren et al, 1990;Kappes et al, 1992). The tcRNA was subjected to quantitative real-time reverse transcriptase-PCR (qPCR) analysis, as previously described (Erikson-Hagen et al, 2005;Wright et al, 2008). Briefl y, the primer sets listed in Table 2 were used to generate intron-spanning cDNA amplicons for sheep IGF1, IGF2, IGF1 receptor (IGF1R), IGF2 receptor (IGF2R), insulin receptor (INSR), and ribosomal protein subunit 15 (RPS15), which were sequenced to verify authenticity and used to generate standard curves spanning from 10 to 1 × 10 6 pg starting quantity.…”
Section: Liver Mrna Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…2 by methods previously described by this laboratory (Warren et al, 1990;Kappes et al, 1992). The tcRNA was subjected to quantitative real-time reverse transcriptase-PCR (qPCR) analysis, as previously described (Erikson-Hagen et al, 2005;Wright et al, 2008). Briefl y, the primer sets listed in Table 2 were used to generate intron-spanning cDNA amplicons for sheep IGF1, IGF2, IGF1 receptor (IGF1R), IGF2 receptor (IGF2R), insulin receptor (INSR), and ribosomal protein subunit 15 (RPS15), which were sequenced to verify authenticity and used to generate standard curves spanning from 10 to 1 × 10 6 pg starting quantity.…”
Section: Liver Mrna Analysismentioning
confidence: 99%
“…After 40 cycles of qPCR, with a fl uorescence measurement after each cycle, a melting curve analysis was initiated at 55ºC, with fl uorescence measured at 0.5°C increments until 95°C. Relative expression of IGF1, IGF2, IGF1R, IGF2R, and INSR was determined by dividing the starting quantity of the mRNA of interest by the starting quantity of RPS15 (Erikson-Hagen., 2005;Wright et al, 2008).…”
Section: Liver Mrna Analysismentioning
confidence: 99%
“…However, in later pregnancy, increasing maternal circulating IGF‐I appears to have no immediate effect on maternal body composition or fetal weight (Harding et al 1997). The extent of IGF‐I actions on the mother is dependent on gestational age, maternal age and nutrition, and whether the pregnancy is a singleton or twin (Table 1: Costine et al 2005; Wallace et al 2006 a ; Kenyon et al 2007; Wright et al 2008; Koch et al 2010). Like the pig, maternal IGF‐I may have most benefit on ovine fetal growth in adverse maternal environments.…”
Section: Maternal Metabolism and Nutrient Partitioningmentioning
confidence: 99%
“…Administration of GH daily at 0.2 mg/kg from d 35 to 55 had no effect on fetal weight by the end of treatment and did not affect fetal weight at d 135 of gestation (Wright et al, 2008). We interpret this to mean that whatever programming effect GH treatment has during very early gestation, the window of opportunity to impart that program is no longer open by as early as d 35 of gestation.…”
Section: Discussionmentioning
confidence: 86%
“…We interpret this to mean that whatever programming effect GH treatment has during very early gestation, the window of opportunity to impart that program is no longer open by as early as d 35 of gestation. Wright et al (2008) chose d 35 to 55 to administer GH because this is the period of gestation in which the placenta is producing GH. However, increases in maternal pituitary GH or peripheral IGF-I during the first 4 wk of gestation may be more critical to affecting the growth of the fetoplacental unit than the GH produced for 20 d by the endometrium during wk 5 to 8 of gestation.…”
Section: Discussionmentioning
confidence: 99%